Comparison of pharmacokinetic and safety profiles between Bemfola(®) and Gonal-f(®) after subcutaneous application

Recombinant human follicle stimulating hormone (r-hFSH) is effective and safe for controlled ovarian stimulation. Bemfola(®) (Finox AG, Burgdorf, Switzerland), a new biosimilar r-hFSH, has proven comparable non-clinical pharmacological profiles to those of the widely used Gonal-f(®) (Serono Pharma S...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Eur J Drug Metab Pharmacokinet
Päätekijät: Wolzt, Michael, Gouya, Ghazeleh, Sator, Michael, Hemetsberger, Thomas, Irps, Charlotte, Rettenbacher, Manfred, Vcelar, Brigitta
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer International Publishing 2015
Aiheet:
Original Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4866993/
https://ncbi.nlm.nih.gov/pubmed/25633239
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13318-015-0257-6
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia